Table of contents

ORIGINAL ARTICLES

• Tumor board in gynecologic oncology (1 February, 2004)

  J. T. Santoso, B. Schwertner, R. L. Coleman, E. V. Hannigan
• Multidisciplinary team working: is it both holistic and effective? (1 February, 2004)

  H. Jefferies, K. K. Chan
• Accuracy of frozen section in diagnosis of ovarian mass (1 February, 2004)

  S. Tangjitgamol, S. Jesadapatrakul, S. Manusirivithaya, C. Sheanakul
• Subjective versus objective nutritional assessment study in women with gynecological cancer: a prospective cohort trial (1 February, 2004)

  K. Alladi, J. T. Santoso, T. Cannada, B. O'FARREL, R. L. Coleman
• Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group (1 February, 2004)

  D. S. Alberts, C. Jiang, P. Y. Liu, S. Wilczynski, M. Markman, M. L. Rothenberg
• Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells (1 February, 2004)

  L. Lelievre, P. Paterlini-Brechot, S. Camatte, E. Tartour, M. Aggerbeck, F. Vilde, F. Lecuru
• The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice

  (1 February, 2004)

  H. Cui, X.-H. Chang, B. Liu, J. Feng, Y. Li, X. Ye, S.-J. Cao, T.-Y. Fu, Y. Yao, H.-N. Qian, H.-Q. Li
• Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer

  (1 February, 2004)

  R. E. J. Howells, K. K. Dhar, P. R. Hoban, P. W. Jones, A. A. Fryer, C. W. E. Redman, R. C. Strange
• Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer (1 February, 2004)

  I. Bruchim, A. Fishman, E. Friedman, I. Goldberg, A. Chetrit, I. Barshack, E. Dekel, G. Hirsh-Yechezkel, B. Modan, J. Kopolovic
• A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging (1 February, 2004)

  I. Skírnisdóttir, T. Seidal, B. Sorbe
• Sentinel lymph node biopsy in cervix and corpus uteri cancers (1 February, 2004)

  L. Lelievre, S. Camatte, M. A. Le Frere-Belda, K. Kerrou, M. Froissart, R. Taurelle, F. Vilde, F. Lecuru
• A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma (1 February, 2004)

  A. Ayhan, R. A. Al, C. Baykal, E. Demirtas, K. YÜCE, A. Ayhan
• Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy (1 February, 2004)

  A. Ayhan, R. A. Al, C. Baykal, E. Demirtas, A. Ayhan, K. YÜCE
• Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India (1 February, 2004)

  C. Duttagupta, S. Sengupta, M. Roy, D. Sengupta, P. Bhattacharya, P. Laikangbam, S. Roy, S. Ghosh, R. Das
• Early-stage vaginal carcinoma – an analysis of 70 patients (1 February, 2004)

  G. R. Otton, J. L. Nicklin, G. J. Dickie, P. Niedetzky, L. Tripcony, L. C. Perrin, A. J. Crandon
• Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3 (1 February, 2004)

  H. Lin, H. Y. Chang, C. C. Huang, C. C. Changchien
• Overall major histocompatibility complex class I expression is not downregulated in cervix cancer, as detected by immunoelectron microscopy (1 February, 2004)

  M. A. Van Eijkeren, J. P. Roovers, V. Oorschot, H. J. Geuze
• Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo

  (1 February, 2004)

  W. S. Ahn, S. M. Bae, J. M. Lee, S. E. Namkoong, J. Y. Yoo, Y.-S. Seo, S. L. Nam, Y.-L. Cho, K. H. Nam, C. K. Kim, Y.-W. Kim
• Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix (1 February, 2004)

  J. Argüello-Ramírez, E. PÉREZ-CÁRDENAS, R. Delgado-Chávez, G. Solorza-Luna, S. Villa-Treviño, F. Arenas-Huertero
• Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study (1 February, 2004)

  H. D. Homesley, G. Boike, G. W. Spiegel
• Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment (1 February, 2004)

  L.-C. Horn, U. Schnurrbusch, K. Bilek, B. Hentschel, J. Einenkel
• Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma (1 February, 2004)

  A. Abargel, I. Avinoach, V. Kravtsov, M. Boaz, M. Glezerman, J. Menczer
• EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV) (1 February, 2004)

  F. Ghaemmaghami, M. Modares, M. Arab, N. Behtash, A. Z. Moosavi, N. Khanafshar, P. Hanjani
• The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation (1 February, 2004)

  A. M. Gillespie, E. A. Lidbury, J. A. Tidy, B. W. Hancock